Influence of the Functional Polymorphisms in the Organic Anion Transporting Polypeptide 1B1 in the Susceptibility to Colorectal Cancer

被引:5
|
作者
Ozhan, Gul [1 ]
Kara, Mehtap [1 ]
Sari, Fatih M. [1 ]
Yanar, Hakan T. [2 ]
Alpertunga, Buket [1 ]
机构
[1] Istanbul Univ, Dept Pharmaceut Toxicol, Fac Pharm, TR-34116 Istanbul, Turkey
[2] Istanbul Univ, Dept Gen Surg, Fac Med, TR-34116 Istanbul, Turkey
关键词
SINGLE NUCLEOTIDE POLYMORPHISMS; GENETIC POLYMORPHISMS; OATP TRANSPORTERS; SLCO1B1; HAPLOTYPES; TOXICITY; PHARMACOKINETICS; IDENTIFICATION; SYSTEMS; IMPACT;
D O I
10.1089/gtmb.2012.0334
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer is an important cause of death throughout the world, and its etiology involves the interaction of genetic and environmental factors. Transporter proteins are important in protecting organs from xenobiotics or toxins. Organic anion-transporting polypeptide 1B1 (OATP1B1) plays role in hepatic uptake and clearance of albumin-bound amphipathic organic compounds, including endogen substances, drugs, or xenobiotics. The SLCO1B1 gene expressing OATP1B1 is highly polymorphic. Up to now, SLCO1BI variants were the focus of several investigations on drug pharmacokinetics and cancer susceptibility. However, no information has been available on association between SLCO1B1 and colorectal cancer risk. Therefore, the study aims to investigate the relationship between colorectal cancer and the functional common variants of SLCO1B1 (388 A > G, -11187 G > A, 521 T > C) and to estimate the prevalence of these variants in the Turkish population. To that end, the distributions of the variants were determined in 100 patients with colorectal cancer and 150 healthy volunteers. SLCO1B1 521 T > C was statistically significantly associated with colorectal cancer risk (odds ratio [OR] = 2.66; 95% confidence interval [CI] = 1.31-5.41; p = 0.0057). In haplotype-based analysis, SLCO1B1 haplotype G(388)-T-11187-T-521 might be associated with the development of colorectal cancer (OR = 4.26; 95% CI = 1.62-11.16; p = 0.002). We believe that the findings may be beneficial to the development of efficacious preventive strategies and therapies for colorectal cancer.
引用
收藏
页码:214 / 218
页数:5
相关论文
共 50 条
  • [21] Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1)
    Lee, Hannah H.
    Ho, Richard H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (06) : 1176 - 1184
  • [22] Interactions of oleanane pentacyclic triterpenoids with human organic anion transporting polypeptide 1B1 and 1B3
    Tian, Yiqing
    Wang, Xue
    Bi, Yajuan
    Li, Xuejuan
    Zhang, Yang
    Yao, Yao
    Zhang, Mingzhe
    Xu, Tong
    Zhang, Youheng
    Gui, Chunshan
    Zhang, Weihua
    Zhang, Chunze
    Yu, Heshui
    Zhang, Youcai
    TOXICOLOGY IN VITRO, 2024, 98
  • [23] Influence of Rifampin-Mediated Organic Anion-Transporting Polypeptide 1B1/1B3 Inhibition on the Pharmacokinetics of Clazosentan
    Juif, Pierre-Eric
    Voors-Pette, Christine
    Ufer, Mike
    Dogterom, Peter
    Dingemanse, Jasper
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (05): : 440 - 444
  • [24] microRNA-206 modulates the hepatic expression of the organic anion-transporting polypeptide 1B1
    El Saadany, Taemer
    van Rosmalen, Belle
    Gai, Zhibo
    Hiller, Christian
    Verheij, Joanne
    Stieger, Bruno
    van Gulik, Thomas
    Visentin, Michele
    Kullak-Ublick, Gerd A.
    LIVER INTERNATIONAL, 2019, 39 (12) : 2350 - 2359
  • [25] Influence of the organic anion transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer
    Han, Ji-Youn
    Lim, Hyeong-Seok
    Lee, Sung Young
    Kim, Heung Tae
    Lee, Jin Soo
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S485 - S485
  • [26] Quantitative assessment of the relevance of organic-anion-transporting-polypeptide 1B1 and 2B1 polymorphisms in fexofenadine pharmacokinetic variants via pharmacometrics
    Jang, Ji-Hun
    Jeong, Seung-Hyun
    Lee, Yong-Bok
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2023, 13 (06) : 660 - 672
  • [27] Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics
    Katz, DA
    Carr, R
    Grimm, DR
    Xiong, H
    Holley-Shanks, R
    Mueller, T
    Leake, B
    Wang, Q
    Han, LX
    Wang, PG
    Edeki, T
    Sahelijo, L
    Doan, T
    Allen, A
    Spear, BB
    Kim, RB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (03) : 186 - 196
  • [28] Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer
    Han, Ji-Youn
    Lim, Hyeong-Seok
    Shin, Eun Soon
    Yoo, Yeon-Kyeong
    Park, Yong Hoon
    Lee, Jong-Eun
    Kim, Heung Tae
    Lee, Jin Soo
    LUNG CANCER, 2008, 59 (01) : 69 - 75
  • [29] How does S-palmitoylation affect the Organic Anion Transporting Polypeptide 1B1 (OATP1B1)?
    Villanueva, Cecilia E.
    Hagenbuch, Bruno
    FASEB JOURNAL, 2022, 36
  • [30] The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1
    Fan, L.
    Zhang, W.
    Guo, D.
    Tan, Z-R
    Xu, P.
    Li, Q.
    Liu, Y-Z
    Zhang, L.
    He, T-Y
    Hu, D-L
    Wang, D.
    Zhou, H-H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (03) : 471 - 476